Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 76.29M
March 31, 2026 66.61M
December 31, 2025 66.58M
September 30, 2025 54.11M
June 30, 2025 54.09M
March 31, 2025 53.98M
December 31, 2024 53.97M
September 30, 2024 53.94M
June 30, 2024 62.25M
March 31, 2024 62.14M
December 31, 2023 61.92M
September 30, 2023 61.82M
June 30, 2023 61.82M
March 31, 2023 61.76M
December 31, 2022 52.10M
September 30, 2022 52.05M
June 30, 2022 41.01M
Date Value
March 31, 2022 40.68M
December 31, 2021 40.63M
September 30, 2021 40.53M
June 30, 2021 32.66M
March 31, 2021 32.59M
December 31, 2020 27.94M
September 30, 2020 27.28M
June 30, 2020 27.22M
March 31, 2020 22.79M
December 31, 2019 22.65M
September 30, 2019 22.56M
June 30, 2019 23.34M
March 31, 2019 23.34M
December 31, 2018 23.34M
September 30, 2018 22.56M
June 30, 2018 22.56M
March 31, 2018 23.34M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 13.79M
CNBX Pharmaceuticals, Inc. 1.476B
GB Sciences, Inc. --
Arvinas, Inc. 65.30M
Definium Therapeutics, Inc. 134.37M